Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The HPV associated disorders market was valued at USD 16.82 Billion in 2025. It is poised to grow at a CAGR of 4.40% during the forecast period of 2026-2035, and reach USD 25.87 Billion by 2035. The market growth is driven by the rising burden of cervical cancer and the expanding rollout of multivalent HPV vaccines and self-collection screening solutions.
Latest News on the HPV Associated Disorders Market (2026)
April 2026: New Study Confirms HPV Vaccine Halves Cancer Risk in Men
A large global database analysis of more than 615,000 vaccinated males aged 9 to 26, published in JAMA Oncology and reported by CNN on 24 April, found that boys and young men who received the nonavalent HPV vaccine had approximately 46% lower risk of developing HPV-related cancers compared with unvaccinated peers. The findings reinforce the case for extending vaccination coverage beyond cervical cancer prevention, expanding the addressable market for HPV-associated disorder diagnostics and prevention strategies.
March 2026: Swedish 18-Year Study Confirms Sustained HPV Vaccine Protection
A Karolinska Institutet cohort study of 926,362 girls and women published in The BMJ demonstrated sustained risk reduction of invasive cervical cancer through 18 years of follow-up, with no evidence of waning protection. Coverage by The Guardian noted that women vaccinated before age 17 showed an incidence rate ratio of 0.21 versus unvaccinated women, strengthening the long-term commercial outlook for HPV vaccination programmes and the broader continuum of HPV-associated disease management.
Key Market Trends and Insights
- By product type, the prophylactic vaccines segment is expected to lead the market in the forecast period.
- Based on indication, the cervical cancer segment held approximately 63% of the market in the historical period.
- By distribution channel, the hospital pharmacies segment led the market with around 54% share of the market in the historical period.
Market Size & Forecast
- Market Size in 2025: USD 16.82 Billion
- Projected Market Size in 2035: USD 25.87 Billion
- Compound Annual Growth Rate (CAGR) of 2026 to 2035: 4.40%
Compound Annual Growth Rate
4.4%
Value in USD Billion
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
HPV Associated Disorders Market Overview
HPV associated disorders are a group of conditions caused by persistent infection with the human papillomavirus, including cervical and anal intraepithelial neoplasia, cervical cancer, anal cancer, genital warts, and head and neck cancers. The market covers preventive vaccines, antiviral and immunomodulatory therapies, molecular diagnostics, and surgical care. The market was valued at USD 16.82 Billion in 2025 and is poised to grow at a CAGR of 4.40%. The growth is supported by a growing elimination initiative, expanding multivalent vaccination programs, and increasing adoption of molecular HPV testing across primary care.
HPV Associated Disorders Market Growth Drivers
Rising Global Burden of Cervical Cancer to Accelerate Market Growth
The increasing burden of cervical cancer is the primary catalyst for HPV vaccination, screening, and therapeutic demand. According to the World Health Organization, cervical cancer caused 660,000 new cases and 350,000 deaths globally in 2022, with more than 95% of cases attributable to HPV infection. This sustained epidemiological pressure continues to support the HPV-associated disorders market growth across vaccines, diagnostics, and therapeutic franchises.
HPV Associated Disorders Market Trends
Some of the notable trends in the market are increasing adoption of HPV screening innovations, expansion of vaccine coverage, and rising focus on preventive oncology.
Indigenous HPV Diagnostic Innovation are Expected to Boost the Market Value
The rising adoption of cost-effective HPV diagnostic technologies is strengthening preventive healthcare strategies in the market. For instance, in April 2025, India’s Ministry of Science & Technology reviewed indigenously developed HPV test kits under a national initiative led by DBT, BIRAC, and ICMR. The program emphasized affordable, mass cervical cancer screening, addressing India’s high burden, where one in five global cases occurs. This advancement is likely to enhance early detection capabilities and improve screening penetration, thereby boosting the HPV-associated disorders market growth across major economies.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
HPV Associated Disorders Market Segmentation
Market Breakup by Product Type
- Prophylactic Vaccines
- Therapeutic Vaccines
- Diagnostic Assays
- Topical Treatments
- Systemic Therapies
- Others
Market Breakup by Indication
- Cervical Cancer
- Genital Warts
- Oropharyngeal Cancers
- Recurrent Respiratory Papillomatosis
- Anal Cancer
- Vaginal and Vulvar Cancers
- Penile Cancer
- Others
Market Breakup by End-User
- Hospitals & Specialty Clinics
- Diagnostic Laboratories
- Academic & Research Institutions
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Breakup by Country
- United States
- United Kingdom
- Germany
- France
- Italy
- Spain
- Japan
- India
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
HPV Associated Disorders Market Share
Cervical Cancer Segment Leads the Market Segmentation by Indication
The cervical cancer segment is expected to lead the market, accounting for nearly 63% of the revenue share in the historical period. The dominance is driven by the rising prevalence of cervical malignancies associated with persistent high-risk HPV infections and the increasing adoption of molecular screening. The growth is further supported by expanded screening guidelines, improved insurance coverage, and the World Health Organization’s ongoing cervical cancer elimination initiative. Overall, sustained clinical burden and strengthened preventive healthcare strategies are expected to maintain the segment’s leading position throughout the forecast period.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
HPV Associated Disorders Market Analysis by Region
Among all the regions, the United States is expected to lead the market, supported by mature screening infrastructure, robust vaccine uptake, and concentrated R&D. In May 2024, the FDA approved Roche's HPV self-collection solution, one of the first such tools in the United States, expanding cervical cancer screening access. Regions such as India and Japan are anticipated to grow at the fastest pace owing to rising disease awareness, expanding national vaccination programs, and government-led screening initiatives.
Leading Players in the HPV Associated Disorders Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Merck & Co., Inc.
Merck & Co., Inc. is a leading biopharmaceutical company and a global leader in HPV prevention through its GARDASIL and GARDASIL 9 vaccines, which protect against multiple HPV types causing cervical and other cancers. The company has announced the development of a novel multivalent HPV vaccine and single-dose regimen clinical trials to expand protection and improve access, strengthening its role in the market.
GSK plc
GSK plc is a global vaccine-focused pharmaceutical company offering Cervarix, a bivalent HPV vaccine targeting HPV 16 and 18 to prevent cervical cancer. The company plays a key role in public immunization programs and continues supporting HPV-related disease prevention efforts, contributing significantly to market expansion.
F. Hoffmann-La Roche AG
F. Hoffmann-La Roche AG is a global leader in diagnostics, providing HPV screening solutions such as the cobas HPV test and CINtec® assays for early detection of cervical cancer. Roche is advancing HPV self-collection technologies and expanding access to screening, reinforcing its strong position in HPV diagnostics within the HPV associated disorders market.
Pfizer Inc.
Pfizer Inc. is a global biopharmaceutical company engaged in vaccines and oncology research relevant to HPV-associated diseases. The company has evaluated co-administration of HPV vaccines and continues to support immunization and cancer prevention studies, contributing to HPV-related disease management and strengthening its presence in the market.
Other key players in the market are AstraZeneca PLC, Biocon Limited, QIAGEN N.V., Becton, Dickinson and Company, Inovio Pharmaceuticals, Inc., and Serum Institute of India Private Limited.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Key Questions Answered in the HPV Associated Disorders Market Report
- What was the HPV associated disorders market value in 2025?
- What is the HPV associated disorders market forecast outlook for 2026-2035?
- What major factors aid the demand for the HPV associated disorders market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major HPV associated disorders market trends?
- Which product type is expected to dominate the market segment?
- Which indication is projected to lead the market segment?
- Which end-user is anticipated to drive the market segment?
- Which distribution channel is anticipated to lead the HPV associated disorders market?
- Who are the key players in the HPV associated disorders market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
